Roswell Park Day of Giving 2020

Shannon: Wife, mom of two, teacher and runner. Diagnosed with melanoma at age 38.
Shannon: Wife, mom of two, teacher and runner. Diagnosed with melanoma at age 38.

Melanoma

Welcome to our team page for the Roswell Park Day of Giving. We are so excited for this 24-hour give-a-thon!

Why?

Because our Day of Giving is an opportunity for you to direct your donation to research areas that mean the most to you. By giving to melanoma cancer research, you’re making a huge impact for patients facing this disease.

Melanoma is a potentially deadly type of skin cancer that 1 in 58 people will be at risk of developing. Melanoma accounts for only 1% of skin cancers but causes a large majority of skin cancer deaths. When melanoma is found and treated early, the survival rate is almost 100%. Early detection and research for improved treatments are part of the reason we have more melanoma cancer survivors today than ever before, but it can be more challenging to treat if detected late.

Here at Roswell Park, donations allow us to pursue and advance research, bring the latest treatment options to our patients and help them maintain the best possible quality of life. Our team is committed to increasing survival rates, developing new treatments, providing access to new therapies through clinical trials, and offering supportive services for our patients throughout their cancer journey.

But we need your help! Please consider making a donation today as part of our Day of Giving. The support of generous donors like you allows us to stay on the cutting edge of melanoma cancer research and to provide compassionate care to all our patients. Your donation will be used to accelerate promising clinical trials in immunotherapy treatments for melanoma. And if you’re looking to create an even bigger impact, you can join our team by clicking the button on this page and fundraise on our behalf!

Thank you for making a difference in honor of all the patients and families we serve! 

View More
Share with Friends in:
View More